Study of Selumetinib (AZD6244)(ARRY-142886) in Combination With Irinotecan in Previously Treated Patients With Colorec
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether treatment with Selumetinib (AZD6244)
(Hyd-Sulfate) in combination with Irinotecan as a second treatment in patients with K-ras or
B-raf mutation will prevent tumor progression and prolong progression free survival.